StonvexLoading…
StonvexStonvexStonvexCore line items from NYT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $712.24M | $2.82B | $2.02B | $1.32B |
Operating Income | $90.62M | $431.56M | $269.97M | $165.19M |
Net Income | $87.92M | $343.98M | $214.14M | $132.50M |
EPS (Diluted) | $0.54 | $2.09 | $1.30 | $0.80 |
Total Assets | $2.86B | $3.00B | $2.89B | $2.81B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $186.73M | $255.44M | $249.34M | $198.24M |
Free Cash Flow OCF − CapEx | $81.51M | $550.50M | $392.88M | $193.15M |
Shares Outstanding | 163.70M | 164.94M | 164.73M | 164.79M |